Biosynex SA (EPA:ALBIO)
France · Delayed Price · Currency is EUR 0.8300
+0.0120 (1.47%)
Nov 6, 2026, 5:35 PM CET
Biosynex Market Cap
Biosynex has a market cap or net worth of €15.3 million as of November 6, 2026. It is the 37,861st most valuable company in the world and the 475th biggest in France. Its market cap has increased by 51.11% in one year.
Market Cap
15.30M
Enterprise Value
68.84M
Revenue
89.88M
Global Rank
Country Rank
#475 France
PE Ratio
n/a
ChartMarket Cap Chart
Since March 25, 2011, Biosynex's market cap has increased from 8.12M to 15.30M, an increase of 88.35%. That is a compound annual growth rate of 4.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 15.30M | 36.91% |
| Dec 31, 2025 | 11.17M | -39.63% |
| Dec 31, 2024 | 18.51M | -78.44% |
| Dec 29, 2023 | 85.85M | -39.13% |
| Dec 30, 2022 | 141.04M | -51.35% |
| Dec 31, 2021 | 289.89M | 91.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 265.30M |
| Median Technologies | 134.91M |
| Guerbet | 80.92M |
| Theraclion | 51.25M |
| Novacyt | 29.73M |
| Diagnostic Medical Systems | 23.54M |
| Ikonisys | 22.18M |
| Implanet | 19.24M |